Skip to main content

Advertisement

Table 5 Annual percentage tibial bone expansion from baseline over 24 months

From: Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial

  MPC + HA HA alone p*
Medial tibial plateau
 6 months 0.8 (3.9) 4.2 (3.4) 0.13
 12 months –1.9 (4.0) 1.5 (3.6) 0.17
 24 months 0.1 (1.7) 0.8 (0.9) 0.43
Lateral tibial plateau
 6 months 0.4 (4.2) 3.6 (3.6) 0.17
 12 months –0.2 (4.0) 1.9 (2.8) 0.35
 24 months –1.8 (2.6) 1.2 (3.5) 0.16
Total tibial plateau
 6 months 0.5 (2.4) 4.0 (2.3) 0.02
 12 months –1.2 (2.8) 1.7 (2.0) 0.09
 24 months –0.7 (1.5) 1.0 (1.1) 0.09
  1. Data are reported as mean (SD)
  2. * For difference between two groups using independent samples t test
  3. HA hyaluronan, MPC mesenchymal precursor cell